A Comparison of Costs among Patients with Type 2 Diabetes Mellitus Who Initiated Therapy with Exenatide or Insulin Glargine

Author: Misurski Derek  

Publisher: Adis International

ISSN: 1175-5652

Source: Applied Health Economics and Health Policy, Vol.7, Iss.4, 2009-12, pp. : 245-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content